增生细胞核抗原与大肠癌分化、分期及预后的关系

Analysis of proliferative activity in colorectal carcinoma by detection of the proliferating cell nuclear antigen and its relationship to differentiation, clinical stage and prognosis

  • 摘要: 本文对90例大肠癌、101例大肠癌断端及15例正常大肠粘膜组织用单克隆抗体PC10经SABC免疫组化法进行PCNA指数测定。结果显示:PCNA指数在正常大肠粘膜组织为零,在大肠癌组织为100%表达,均值为51.4%,在大肠癌断端为80.2%表达,均值为19.4%;大肠癌PCNA指数的高低似与病程进展有关,大肠癌DUKE分期A期和B期者PCNA指数显著低于DUKEC期或D期者;大肠癌PCNA指数大小似与肿瘤的预后有关,术后3年未复发者PCNA指数均值在癌组织为38.8%,在切除断端为3.5%,显著低于术后复发、转移或因癌死亡者在癌区67%和断端39.8%的PCNA指数均值。本结果提示PCNA指数均值与大肠癌分化程度无明显平行关系,这是独立于肿瘤分化程度的另一个判断预后的指标。

     

    Abstract: n this paper, 90 cases of colorectal carcinoma tissue, 101 cases of remote margin, and 15 cases of normal human colorectal tissues were studied by immunohistochemical staining with McAb PC10 for analysis of the relationship between proliferating cell nuclear antigen (PCNA) index assessment and prognosis of colorectal carcinoma. The results showed that PCNA indices in normal colorectal tissues were 0% positive, but in colorectal cancer tissues and remote mucosa were 100% and 80.2% positive, respectively. The PCNA index, whether high or low, seemed to correlate with the clinical stage; Dukes A and B PC10 scores were much lower than Dukes C and D. PCNA indices in colorectal carcinomas and remote mucosa were related to the progress of disease and the prognosis. After at least three years of follow-up postoperatively, in non-recurrent patients, the average PCNA index in cancer tissues and remote mucosa was 38.8% and 3.5%, whereas in patients with recurrence, metastasis, or death, the PCNA index in cancer tissues and remote mucosa was 67% and 39.8% (P < 0.001). Our study indicates that the PCNA index does not correlate with histological grade; it may be another independent factor in predicting tumor recurrence or identifying patient prognosis.

     

/

返回文章
返回